BREAST CANCER

Swiss drugmaker Roche struck a cautious note on 2011, as the sector grapples with U.S. healthcare reforms and a push in Europe for lower drug prices, after growth of its top-seller Avastin slowed sharply in 2010.

Swiss drugmaker Roche joined peers in striking a cautious note on 2011 as the sector grapples with U.S. healthcare reforms and a push in Europe for lower drug prices.

Scientists in the United Kingdom have identified a “rogue” gene that attacks and breaks down a naturally-occurring protein in the body which normally prevents cancer cells spreading. By blocking the WWP2 gene, which is an enzymic bonding agent found inside cancer cells, levels of the natural inhibitor are boosted and the cancer cells remain dormant.

The world is greeting the news with reserve as John lost his wife to cancer just a month back

Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.

P Diddy says he is not responsible for breast cancer charities not getting funds for a party he hosted for a club

The top after-market NASDAQ stock market losers are: Chart Industries, Corinthian Colleges, DSP Group, Macatawa Bank, MIPS Technologies, BSD Medical, NetScout Systems, Constant Contact, Stonemor Partners, and Monro Muffler Brake.

Using particles of gold, ultrasound and an infrared laser, scientists can now see into the body in m,ore detail than ever before.

Swiss pharma giant Roche said it plans to cut 4,800 jobs worldwide over the next two years due to mounting cost pressures in healthcare -particularly in the US and Europe - and increasing hurdles for the approval and pricing of new medicines.

Sixty years ago, a woman had just a 25 percent chance of living 10 years if she got a breast cancer diagnosis. Now the survival rate is more than 75 percent, U.S. doctors reported on Wednesday.

Scientists have found a region of DNA that can increase or decrease the high chance of breast cancer linked to a particular gene variant - a finding that could help doctors keep a closer eye on women most at risk.

Atomic bomb blast victims lucky enough to survive one cancer have a high risk of developing a second, U.S. researchers said on Wednesday, in a study that offers new insights about cancer risks from radiation exposure.

Women who drink alcohol regularly are at a greater risk of breast cancer, repeated research has shown. It shows that alcohol reduces a person's immunity against fighting the cancer cells, and it leads to cancer developing in the milk producing glands that are connected to the ducts carrying milk to the nipple. Studies have shown that high estrogen levels are the main cause of cancer developing in ...

Tests of tumor samples taken before and after treatment with an experimental melanoma pill helped researchers find the right dose in early stage testing, an approach that may boost the drug's chances of success and aid in developing others, company researchers said on Tuesday.

Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday.

Hormone replacement therapy after menopause may interfere with the accuracy of mammograms used to screen for breast cancer -- and the risk may be greater with hormones delivered by patch or injection compared with pills, a new study finds.

Developing countries will bear 60 percent of the world's cancer burden by 2020 and 70 percent by 2030, but are not prepared for the looming crisis, cancer experts warned in a report on Thursday

Cigarette smoking has been clearly linked to increased risks of a number of cancers, including cancers of the lungs, colon, pancreas and bladder. But studies have yielded conflicting results as to whether smoking may boost a woman's odds of developing breast cancer.

Cancer costs the world economy $895 billion per year, according to a study on the economic cost of causes of deaths conducted by the American Cancer Society (ACS) and LIVESTRONG.

A device that can detect if one has cancer or not through his or her breath alone can now also detect the type of cancer the patient has, according to scientists who developed the breath test.

After beating cancer, while the body is clear from harm's way, the mind of survivors may not be as ready to go back to its normal cancer-free state.